Osteonecrosis of the Jaw - Available in English, French, Italian, German and Spanish
This module focuses on the effective management of osteonecrosis of the jaw (ONJ) and its challenges. ONJ is a side effect associated with a number of bone-targeting agents approved for use in cancer patients with bone metastases. We look at the importance of communication and collaboration between oncologists, dentists and oral surgeons when it comes to preventing, diagnosing and effectively treating cases of ONJ.
Published September 2017.